Transient gestational hypothyroxinemia accelerates and enhances ulcerative colitis-like disorder in the male offspring

dc.contributor.affiliationUniversidad Andres Bello
dc.contributor.affiliationPontificia Universidad Catolica de Chile
dc.contributor.affiliationUniversidad de Las Americas - Chile
dc.contributor.affiliationUniversidad Autonoma de Chile
dc.contributor.affiliationInstitut National de la Sante et de la Recherche Medicale (Inserm)
dc.contributor.affiliationNantes Universite
dc.contributor.authorRivera, Juan Carlos
dc.contributor.authorOpazo, Ma. Cecilia
dc.contributor.authorHernandez-Armengol, Rosario
dc.contributor.authorAlvarez, Oscar
dc.contributor.authorMendoza-Leon, Maria Jose
dc.contributor.authorCaamano, Esteban
dc.contributor.authorGatica, Sebastian
dc.contributor.authorBohmwald, Karen
dc.contributor.authorBueno, Susan M.
dc.contributor.authorGonzalez, Pablo A.
dc.contributor.authorNeunlist, Michel
dc.contributor.authorBoudin, Helene
dc.contributor.authorKalergis, Alexis M.
dc.contributor.authorRiedel, Claudia A.
dc.date.accessioned2024-01-29T18:38:02Z
dc.date.available2024-01-29T18:38:02Z
dc.date.issued2024-01-04
dc.description.abstractIntroduction Gestational hypothyroxinemia (HTX) is a condition that occurs frequently at the beginning of pregnancy, and it correlates with cognitive impairment, autism, and attentional deficit in the offspring. Evidence in animal models suggests that gestational HTX can increase the susceptibility of the offspring to develop strong inflammation in immune-mediated inflammatory diseases. Ulcerative colitis (UC) is a frequent inflammatory bowel disease with unknown causes. Therefore, the intensity of ulcerative colitis-like disorder (UCLD) and the cellular and molecular factors involved in proinflammatory or anti-inflammatory responses were analyzed in the offspring gestated in HTX (HTX-offspring) and compared with the offspring gestated in euthyroidism (Control-offspring). Methods Gestational HTX was induced by the administration of 2-mercapto-1-methylimidazole in drinking water to pregnant mice during E10–E14. The HTX-offspring were induced with UCLD by the acute administration of dextran sodium sulfate (DSS). The score of UCLD symptomatology was registered every day, and colon histopathology, immune cells, and molecular factors involved in the inflammatory or anti-inflammatory response were analyzed on day 6 of DSS treatment. Results The HTX-offspring displayed earlier UCLD pathological symptoms compared with the Control-offspring. After 6 days of DSS treatment, the HTX-offspring almost doubled the score of the Control-offspring. The histopathological analyses of the colon samples showed signs of inflammation at the distal and medial colon for both the HTX-offspring and Control-offspring. However, significantly more inflammatory features were detected in the proximal colon of the HTX-offspring induced with UCLD compared with the Control-offspring induced with UCLD. Significantly reduced mRNA contents encoding for protective molecules like glutamate-cysteine ligase catalytic subunit (GCLC) and mucin-2 (MUC-2) were found in the colon of the HTX-offspring as compared with the Control-offspring. Higher percentages of Th17 lymphocytes were detected in the colon tissues of the HTX-offspring induced or not with UCLD as compared with the Control-offspring. Discussion Gestational HTX accelerates the onset and increases the intensity of UCLD in the offspring. The low expression of MUC-2 and GCLC together with high levels of Th17 Lymphocytes in the colon tissue suggests that the HTX-offspring has molecular and cellular features that favor inflammation and tissue damage. These results are important evidence to be aware of the impact of gestational HTX as a risk factor for UCLD development in offspring.
dc.description.sponsorshipMillennium Institute on Immunology and Immunotherapy PROGRAMA ICM -ANID [ICN2021_045]; FONDECYT [1191300, 1231905, 1231851, 1212075, 11221280]; FONDEF/IDeA [ID20I10082]; PUENTE-2023-18; ANID [21211419, 21202356]; The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research was funded by the Millennium Institute on Immunology and Immunotherapy PROGRAMA ICM -ANID, ICN2021_045; FONDECYT #1191300, #1231905, #1231851, #1212075, and #11221280; FONDEF/IDeA ID20I10082, and PUENTE-2023-18. MM and EC thanks to ANID for providing a Ph.D. Scholarship [21211419 and 21202356, respectively].
dc.format.mimetypeapplication/pdf
dc.identifier.citationFrontiers in Endocrinology, 14, 1269121. https://doi.org/10.3389/fendo.2023.1269121
dc.identifier.doihttps://doi.org/10.3389/fendo.2023.1269121
dc.identifier.folio11221280
dc.identifier.folio1191300
dc.identifier.folio1212075
dc.identifier.folio1231851
dc.identifier.folio1231905
dc.identifier.folio21211419
dc.identifier.folio21202356
dc.identifier.issn1664-2392
dc.identifier.orcidhttps://orcid.org/0000-0002-6794-7544
dc.identifier.orcidhttps://orcid.org/0000-0003-1892-5071
dc.identifier.orcidhttps://orcid.org/0009-0004-5458-1012
dc.identifier.orcidhttps://orcid.org/0000-0002-9714-2384
dc.identifier.orcidhttps://orcid.org/0000-0003-4263-9294
dc.identifier.pmid38239991
dc.identifier.researcheridJQX-2530-2023
dc.identifier.researcheridKSL-5357-2024
dc.identifier.researcheridAAF-2934-2021
dc.identifier.researcheridL-1973-2013
dc.identifier.researcheridF-5669-2012
dc.identifier.researcheridK-2388-2015
dc.identifier.researcheridK-2400-2015
dc.identifier.researcheridHOH-2917-2023
dc.identifier.rorhttps://ror.org/01qq57711
dc.identifier.rorhttps://ror.org/04teye511
dc.identifier.rorhttps://ror.org/05j6ybs54
dc.identifier.rorhttps://ror.org/010r9dy59
dc.identifier.rorhttps://ror.org/02vjkv261
dc.identifier.rorhttps://ror.org/01kbkse74
dc.identifier.rorhttps://ror.org/03gnr7b55
dc.identifier.rorhttps://ror.org/0166e9x11
dc.identifier.scopusauthorid55360870100
dc.identifier.scopusauthorid55966517500
dc.identifier.scopusauthorid58614598300
dc.identifier.scopusauthorid58814104700
dc.identifier.scopusauthorid57221338973
dc.identifier.scopusauthorid60641492000
dc.identifier.scopusauthorid59805807300
dc.identifier.scopusauthorid40260992400
dc.identifier.scopusauthorid7003686736
dc.identifier.scopusauthorid57206413101
dc.identifier.scopusauthorid6701416352
dc.identifier.scopusauthorid6602785341
dc.identifier.scopusauthorid6601943684
dc.identifier.scopusauthorid24764954100
dc.identifier.urihttps://repositorio.udla.cl/handle/udla/1181
dc.language.isoeng
dc.publisherFRONTIERS MEDIA SA
dc.relation.fundingFondo Nacional de Desarrollo Científico y Tecnológico, FONDECYT, (11221280, 1191300, 1212075, 1231851, 1231905, FONDEF/IDeA ID20I10082, PUENTE-2023-18)
dc.relation.fundingFondo Nacional de Desarrollo Científico y Tecnológico, FONDECYT
dc.relation.fundingMillennium Institute on Immunology and Immunotherapy PROGRAMA ICM -ANID [ICN2021_045]
dc.relation.fundingFONDECYT [1191300, 1231905, 1231851, 1212075, 11221280]
dc.relation.fundingFONDEF/IDeA [ID20I10082]
dc.relation.fundingPUENTE-2023-18
dc.relation.fundingANID [21211419, 21202356]
dc.relation.isindexedbyWeb of Science
dc.relation.issn1664-2392
dc.rightsCreative Commons Attribution 4.0 International
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceFRONTIERS IN ENDOCRINOLOGY
dc.source.urihttps://doi.org/10.3389/fendo.2023.1269121
dc.subjectgestational hypothyroxinemia
dc.subjectulcerative colitis
dc.subjectcolon inflammation
dc.subjectimmune cells
dc.subjectautoimmunity
dc.subjectradical oxygen species
dc.subject.lcshColitis ulcerativa.
dc.subject.lcshAutoinmunidad.
dc.subject.lcshAutoimmunity.
dc.titleTransient gestational hypothyroxinemia accelerates and enhances ulcerative colitis-like disorder in the male offspring
dc.title.alternativeTransient gestational hypothyroxinemia accelerates and enhances ulcerative colitis-like disorder in the male offspring.
dc.typejournal article
dc.type.coarhttp://purl.org/coar/resource_type/c_6501
dc.type.driverinfo:eu-repo/semantics/article
oaire.citation.titleFRONTIERS IN ENDOCRINOLOGY
oaire.citation.volume14
oaire.fundingReference.awardNumber11221280
oaire.fundingReference.awardNumber1191300
oaire.fundingReference.awardNumber1212075
oaire.fundingReference.awardNumber1231851
oaire.fundingReference.awardNumber1231905
oaire.fundingReference.awardNumber21211419
oaire.fundingReference.awardNumber21202356
oaire.fundingReference.funderNameAgencia Nacional de Investigación y Desarrollo (ANID)
udla.curacion.controljmvg
udla.oecd.area3 Ciencias Médicas y de la Salud
udla.oecd.discipline3.1.9 Patología
udla.oecd.subarea3.1 Medicina Básica

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Rivera et al 2024 Transient gestational hypothyroxinemia accelerates and enhances ulcerative colitis-like disorder in the male offspring.pdf
Size:
9.38 MB
Format:
Adobe Portable Document Format
Description:
Rivera et al 2024 Transient gestational hypothyroxinemia accelerates and enhances ulcerative colitis-like disorder in the male offspring

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections